|Dr. Dewan Fazlul Hoque Chowdhury||Chairman, CEO, Pres & Interim CFO||103,77k||N/A||1973|
|Mr. Christopher J. Avery||VP of Global Bus. Operations||N/A||N/A||1963|
|Mr. Bashir Timol||Chief Bus. Officer & Director||N/A||N/A||1974|
|Ms. Kathryn Farrar||Financial Controller||N/A||N/A||1976|
Nemaura Medical Inc., a medical technology company, discovers, develops, and commercializes diagnostic medical devices. It provides sugarBEAT, a non-invasive continuous glucose monitoring device for use by persons with Type I and Type II diabetes, as well as for screening pre-diabetic patients. The company was founded in 2009 and is based in New York, New York.
Nemaura Medical Inc.s ISS Governance QualityScore, Stand N/A, lautet N/A. Die grundlegenden Scores sind Audit: N/A, Vorstand: N/A, Shareholderrechte: N/A, Kompensation: N/A.